Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Business
TSMC to withdraw GaN semiconductor business in 2 years
07/04/2025 12:17 PM - Politics
Taiwan's ambassador to Holy See presents Letter of Credence
07/04/2025 10:55 AM - Society
Brief showers forecast for Friday; tropical storms may be forming
07/04/2025 10:34 AM - Business
U.S. dollar down in Taipei trading
07/04/2025 10:20 AM - Society
Taiwan headline news
07/04/2025 09:57 AM